Support National Blood Cancer Awareness Month

Act Now - Support National Blood Cancer Awareness Month Resolution

--------------------------------------------------------------------------------

Recognizing the need for increased education, research and advocacy for people whose lives have been affected by a blood cancer diagnosis, U.S. Reps. Walter Jones and Betsy Markey have introduced a Congressional resolution that would designate September 2010 as Blood Cancer Awareness Month. Urge your U.S. Representative to become a co-sponsor of this Congressional resolution.

Take Action Now!

We need 100 co-sponsors for the resolution to gain consideration by the House. Please, call the Congressional switchboard at (202) 225-3121 and ask to speak to your representative, or send them an email and ask that they become co-sponsors of the Blood Cancer Awareness Month resolution. Remember that every phone call and letter counts, so be sure to send this message on to your friends, loved ones and other members of the blood cancer community. If you need help finding out who your legislator is, please visit LLS's Legislator Search tool here.

Please act now!

Talking Points:

Ask to speak with a staff member or leave a message for your member of Congress.
Introduce yourself as a constituent, explain what lymphoma and the blood cancers are, and briefly tell your/ your loved one's story about living with the disease.
Explain that Representatives Walter Jones and Betsy Markey have introduced a resolution which would designate September of 2010 as Blood Cancer Awareness Month.
Ask them to contact Rep. Jones' or Markey's office and become a co-sponsor of the resolution.
Thank them for their time and ask them to advise you of the action they take in response to your request (leave your contact information).

Blog Category: 

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap